Clinical Trial

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients

Study acronym: WEVIB-HEMI
Recruiting
View on ClinicalTrials.gov →
Summary
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Trial Details
NCT Number NCT07641790
Lead Sponsor University of Faisalabad
Conditions Hemiplegia, Stroke
Enrollment 30 participants
Start Date 2026-02-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-11